Quest Diagnostics (DGX) Tops Q4 EPS by 26c, Revenues Beat; Offers FY20 EPS/Revenue Outlook
Go back to Quest Diagnostics (DGX) Tops Q4 EPS by 26c, Revenues Beat; Offers FY20 EPS/Revenue Outlook| Quest Diagnostics (NYSE: DGX) | Delayed: 197.15 +3.57 (1.84%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $193.58 | 52 Week High | $86.85 | |||
| Open | $195.78 | 52 Week Low | $59.66 | |||
| Day High | $197.79 | P/E | 37.13 | |||
| Day Low | $194.15 | EPS | $5.31 | |||
| Volume | 275,188 | |||||

